Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

News
1 - 10of about 332 News
1 - 10of about 332 News
May 23, 2023
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer issues new senior bonds with a volume of 3 billion euros
READ MORE
May 16, 2023
Not intended for UK Media
Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
READ MORE
May 11, 2023
Bayer Group business performance in the first quarter of 2023:
Slow start to the year as expected
READ MORE
May 03, 2023
Bayer and Cat Creek Energy Sign Landmark Renewable Energy Deal
READ MORE
April 28, 2023
CEO Werner Baumann at the Annual Stockholders’ Meeting:
“Bayer has excellent prospects for the future”
READ MORE
March 23, 2023
Not intended for U.S. and UK Media
Bayer expands global clinical program for darolutamide in prostate cancer
READ MORE
March 21, 2023
UN 2023 Water Conference:
Bayer pledges to help tackle global water crisis with new water strategy
READ MORE
March 20, 2023
Not intended for U.S. and UK Media
Nubeqa™ (darolutamide) approved for additional prostate cancer indication in China
READ MORE
March 14, 2023
Bayer collaborates with Microsoft to unveil new cloud-based enterprise solutions, advancing innovation and transparency in the agri-food industry
READ MORE
March 01, 2023
Not intended for U.S. and UK Media
Nubeqa™ (darolutamide) receives EU approval for additional indication in prostate cancer
READ MORE
1 - 10of about 332 News
1 - 10of about 332 News

 

Subscribe To Our Latest News 

Ad-Hoc Releases
Discover Bayer's Latest Ad-Hoc Releases
read more